HemosIL Chromogenic Factor IX— 510(k) K230852

Substantially Equivalent

Instrumentation Laboratory Company

FDA 510(k) clearance K230852 for HemosIL Chromogenic Factor IX, Substantially Equivalent on 2023-12-13. Applicant: Instrumentation Laboratory Company.

Clearance details

Applicant
Instrumentation Laboratory Company
Product code
Code GGP
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Bedford, MA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.